AAAAAA
Results: 26-40/40
Authors:
TUXEN MK
SOLETORMOS G
DOMBERNOWSKY P
Citation: Mk. Tuxen et al., TUMOR-MARKERS IN THE MANAGEMENT OF PATIENTS WITH OVARIAN-CANCER, Cancer treatment reviews, 21(3), 1995, pp. 215-245
Authors:
DOMBERNOWSKY P
GEHL J
BOESGAARD M
JENSEN BW
EJLERTSEN B
JENSEN TP
Citation: P. Dombernowsky et al., TREATMENT OF METASTATIC BREAST-CANCER WITH PACLITAXEL AND DOXORUBICIN, Seminars in oncology, 22(6), 1995, pp. 13-17
Authors:
SVENSTRUP B
HERRSTEDT J
BRUNNER N
BENNETT P
WACHMANN H
DOMBERNOWSKY P
Citation: B. Svenstrup et al., SEX-HORMONE LEVELS IN POSTMENOPAUSAL WOMEN WITH ADVANCED METASTATIC BREAST-CANCER TREATED WITH CGS-169-49A, European journal of cancer, 30A(9), 1994, pp. 1254-1258
Authors:
LUND B
RYBERG M
PETERSEN PM
ANDERSON H
THATCHER N
DOMBERNOWSKY P
Citation: B. Lund et al., PHASE-II STUDY OF GEMCITABINE (2',2'-DIFLUORODEOXYCYTIDINE) GIVEN AS A TWICE WEEKLY SCHEDULE TO PREVIOUSLY UNTREATED PATIENTS WITH NONSMALLCELL LUNG-CANCER, Annals of oncology, 5(9), 1994, pp. 852-853
FUCOSYL-GM(1) IN SMALL-CELL LUNG-CANCER - A COMPARISON WITH THE TUMOR-MARKER NEURON-SPECIFIC ENOLASE
Authors:
DRIVSHOLM L
VANGSSTED A
PALLESEN T
HANSEN M
DOMBERNOWSKY P
HIRSCH F
HANSEN HH
Citation: L. Drivsholm et al., FUCOSYL-GM(1) IN SMALL-CELL LUNG-CANCER - A COMPARISON WITH THE TUMOR-MARKER NEURON-SPECIFIC ENOLASE, Annals of oncology, 5(7), 1994, pp. 623-626
Authors:
HIRSCH FR
DOMBERNOWSKY P
HANSEN HH
Citation: Fr. Hirsch et al., TREATMENT OF SMALL-CELL LUNG-CANCER - THE COPENHAGEN EXPERIENCE, Anticancer research, 14(1B), 1994, pp. 317-319
Authors:
MILMAN N
MELLEMGAARD A
HANSEN SH
DOMBERNOWSKY P
Citation: N. Milman et al., BONE-MARROW HEMOSIDERIN IRON AND SERUM IRON STATUS MARKERS IN SMALL-CELL CARCINOMA OF THE LUNG, International journal of oncology, 3(1), 1993, pp. 29-32
Authors:
SOLETORMOS G
NIELSEN D
SCHIOLER V
SKOVSGAARD T
WINKEL P
MOURIDSEN HT
DOMBERNOWSKY P
Citation: G. Soletormos et al., A NOVEL METHOD FOR MONITORING HIGH-RISK BREAST-CANCER WITH TUMOR-MARKERS - CA-15.3 COMPARED TO CEA AND TPA, Annals of oncology, 4(10), 1993, pp. 861-869
Authors:
PEDERSENBJERGAARD J
GJEDDE SB
PHILIP P
RORTH M
SIGSGAARD TC
NIELSEN D
HANSEN M
DOMBERNOWSKY P
LARSEN SO
Citation: J. Pedersenbjergaard et al., EPIRUBICIN AND THE RISK OF LEUKEMIA - NOT SUBSTANTIATED - REPLY, Journal of clinical oncology, 11(7), 1993, pp. 1432-1432
Authors:
SORENSEN JB
STENBYGAARD L
DRIVSHOLM L
DOMBERNOWSKY P
HANSEN HH
Citation: Jb. Sorensen et al., PHASE-II STUDY OF 4'-IODO-4'-DEOXYDOXORUBICIN IN NONRESECTABLE NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 399-402
Authors:
HOGDALL CK
SOLETORMOS G
NIELSEN D
NORGAARDPEDERSEN B
DOMBERNOWSKY P
CLEMMENSEN I
Citation: Ck. Hogdall et al., PROGNOSTIC VALUE OF SERUM TETRANECTIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Acta oncologica, 32(6), 1993, pp. 631-636
Authors:
STENBYGAARD LE
HERRSTEDT J
THOMSEN JF
SVENDSEN KR
ENGELHOLM SA
DOMBERNOWSKY P
Citation: Le. Stenbygaard et al., TOREMIFENE AND TAMOXIFEN IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND CROSS-OVER TRIAL, Breast cancer research and treatment, 25(1), 1993, pp. 57-63
Authors:
KAMBY C
EGSMOSE C
SOLETORMOS G
DOMBERNOWSKY P
Citation: C. Kamby et al., THE DIAGNOSTIC AND PROGNOSTIC VALUE OF SERUM BONE GLA PROTEIN (OSTEOCALCIN) IN PATIENTS WITH RECURRENT BREAST-CANCER, Scandinavian journal of clinical & laboratory investigation, 53(5), 1993, pp. 439-446
Authors:
HERRSTEDT J
SIGSGAARD T
DOMBERNOWSKY P
Citation: J. Herrstedt et al., ANTIEMETIC EFFECTS OF ONDANSETRON AND METOPIMAZINE - REPLY, The New England journal of medicine, 329(18), 1993, pp. 1356-1357
Authors:
SOLETORMOS G
SCHIOLER V
NIELSEN D
SKOVSGAARD T
DOMBERNOWSKY P
Citation: G. Soletormos et al., INTERPRETATION OF RESULTS FOR TUMOR-MARKERS ON THE BASIS OF ANALYTICAL IMPRECISION AND BIOLOGICAL VARIATION, Clinical chemistry, 39(10), 1993, pp. 2077-2083